Login to Your Account



Financings Roundup


Wednesday, January 23, 2013
• Sernova Corp., of London, Ontario, will make a nonbrokered private placement of $2 million to support use of its platform technology to develop therapies for diabetes and other diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription